Working to Eradicate Gynecologic Cancers

Deborah Ricci, PhD

Director- oncology markers
Janssen Research & Development
920 Route 202, P.O. Box 300, Raritan, NJ 08869
Raritan, NJ
USA 08869

Papers:
99 - Featured Poster Effect of BRCA1 and XPG mutations on treatment response to trabectedin and pegylated liposomal doxorubicin in subjects with advanced ovarian cancer: exploratory analysis of phase III OVA-301 study